Tuberculosis Diagnostics Market Research Report by Test Type (Drug-susceptibility Testing, Laboratory Methods, Mantoux Test, Nucleic Acid Testing, and Radiographic Methods) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Tuberculosis Diagnostics Market is expected to grow from USD 2,606.42 Million in 2020 to USD 3,321.04 Million by the end of 2025.
2. The Global Tuberculosis Diagnostics Market is expected to grow from EUR 2,285.35 Million in 2020 to EUR 2,911.95 Million by the end of 2025.
3. The Global Tuberculosis Diagnostics Market is expected to grow from GBP 2,031.68 Million in 2020 to GBP 2,588.73 Million by the end of 2025.
4. The Global Tuberculosis Diagnostics Market is expected to grow from JPY 278,171.10 Million in 2020 to JPY 354,439.46 Million by the end of 2025.
5. The Global Tuberculosis Diagnostics Market is expected to grow from AUD 3,784.86 Million in 2020 to AUD 4,822.59 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Tuberculosis Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Test Type, the Tuberculosis Diagnostics Market studied across Drug-susceptibility Testing, Laboratory Methods, Mantoux Test, Nucleic Acid Testing, and Radiographic Methods.
Based on Geography, the Tuberculosis Diagnostics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Tuberculosis Diagnostics Market including Abbott Laboratories, Alere, Inc., Becton, Dickinson, and Company, BioMerieux SA, Cepheid Inc., F. Hoffmann-La Roche AG, Hain Lifescience GmbH, Hologic Corporation, Siemens AG, and Thermo Fisher Scientific, Inc..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Tuberculosis Diagnostics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Tuberculosis Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Tuberculosis Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Tuberculosis Diagnostics Market?
4. What is the competitive strategic window for opportunities in the Global Tuberculosis Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global Tuberculosis Diagnostics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Tuberculosis Diagnostics Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Tuberculosis Diagnostics Market is expected to grow from USD 2,606.42 Million in 2020 to USD 3,321.04 Million by the end of 2025.
2. The Global Tuberculosis Diagnostics Market is expected to grow from EUR 2,285.35 Million in 2020 to EUR 2,911.95 Million by the end of 2025.
3. The Global Tuberculosis Diagnostics Market is expected to grow from GBP 2,031.68 Million in 2020 to GBP 2,588.73 Million by the end of 2025.
4. The Global Tuberculosis Diagnostics Market is expected to grow from JPY 278,171.10 Million in 2020 to JPY 354,439.46 Million by the end of 2025.
5. The Global Tuberculosis Diagnostics Market is expected to grow from AUD 3,784.86 Million in 2020 to AUD 4,822.59 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Tuberculosis Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Test Type, the Tuberculosis Diagnostics Market studied across Drug-susceptibility Testing, Laboratory Methods, Mantoux Test, Nucleic Acid Testing, and Radiographic Methods.
Based on Geography, the Tuberculosis Diagnostics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Tuberculosis Diagnostics Market including Abbott Laboratories, Alere, Inc., Becton, Dickinson, and Company, BioMerieux SA, Cepheid Inc., F. Hoffmann-La Roche AG, Hain Lifescience GmbH, Hologic Corporation, Siemens AG, and Thermo Fisher Scientific, Inc..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Tuberculosis Diagnostics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Tuberculosis Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Tuberculosis Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Tuberculosis Diagnostics Market?
4. What is the competitive strategic window for opportunities in the Global Tuberculosis Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global Tuberculosis Diagnostics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Tuberculosis Diagnostics Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Test Type Outlook
3.4. Geography Outlook
3.5. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET, BY TEST TYPE
6.1. Introduction
6.2. Drug-susceptibility Testing
6.3. Laboratory Methods
6.4. Mantoux Test
6.5. Nucleic Acid Testing
6.6. Radiographic Methods
7. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States
8. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. South Korea
8.10. Thailand
9. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitor SWOT Analysis
10.5. Competitive Scenario
10.5.1. Merger & Acquisition
10.5.2. Agreement, Collaboration, & Partnership
10.5.3. New Product Launch & Enhancement
10.5.4. Investment & Funding
10.5.5. Award, Recognition, & Expansion
11. COMPANY USABILITY PROFILES
11.1. Abbott Laboratories
11.2. Alere, Inc.
11.3. Becton, Dickinson, and Company
11.4. BioMerieux SA
11.5. Cepheid Inc.
11.6. F. Hoffmann-La Roche AG
11.7. Hain Lifescience GmbH
11.8. Hologic Corporation
11.9. Siemens AG
11.10. Thermo Fisher Scientific, Inc.
12. APPENDIX
12.1. Discussion Guide
12.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Test Type Outlook
3.4. Geography Outlook
3.5. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET, BY TEST TYPE
6.1. Introduction
6.2. Drug-susceptibility Testing
6.3. Laboratory Methods
6.4. Mantoux Test
6.5. Nucleic Acid Testing
6.6. Radiographic Methods
7. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States
8. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. South Korea
8.10. Thailand
9. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitor SWOT Analysis
10.5. Competitive Scenario
10.5.1. Merger & Acquisition
10.5.2. Agreement, Collaboration, & Partnership
10.5.3. New Product Launch & Enhancement
10.5.4. Investment & Funding
10.5.5. Award, Recognition, & Expansion
11. COMPANY USABILITY PROFILES
11.1. Abbott Laboratories
11.2. Alere, Inc.
11.3. Becton, Dickinson, and Company
11.4. BioMerieux SA
11.5. Cepheid Inc.
11.6. F. Hoffmann-La Roche AG
11.7. Hain Lifescience GmbH
11.8. Hologic Corporation
11.9. Siemens AG
11.10. Thermo Fisher Scientific, Inc.
12. APPENDIX
12.1. Discussion Guide
12.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG-SUSCEPTIBILITY TESTING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY LABORATORY METHODS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MANTOUX TEST, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY RADIOGRAPHIC METHODS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AUSTRALIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. CHINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. INDIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. INDONESIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. JAPAN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. MALAYSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. PHILIPPINES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. SOUTH KOREA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. THAILAND TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. ITALY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. NETHERLANDS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. QATAR TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. SAUDI ARABIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. SOUTH AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. SPAIN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. UNITED ARAB EMIRATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: SCORES
TABLE 42. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: BUSINESS STRATEGY
TABLE 43. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: PRODUCT SATISFACTION
TABLE 44. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: RANKING
TABLE 45. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: MERGER & ACQUISITION
TABLE 46. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 47. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 48. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: INVESTMENT & FUNDING
TABLE 49. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 50. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG-SUSCEPTIBILITY TESTING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY LABORATORY METHODS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MANTOUX TEST, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY RADIOGRAPHIC METHODS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AUSTRALIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. CHINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. INDIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. INDONESIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. JAPAN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. MALAYSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. PHILIPPINES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. SOUTH KOREA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. THAILAND TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. ITALY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. NETHERLANDS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. QATAR TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. SAUDI ARABIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. SOUTH AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. SPAIN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. UNITED ARAB EMIRATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: SCORES
TABLE 42. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: BUSINESS STRATEGY
TABLE 43. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: PRODUCT SATISFACTION
TABLE 44. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: RANKING
TABLE 45. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: MERGER & ACQUISITION
TABLE 46. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 47. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 48. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: INVESTMENT & FUNDING
TABLE 49. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 50. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 7. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 8. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 10. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: MARKET DYNAMICS
FIGURE 11. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2020 VS 2025 (%)
FIGURE 13. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025
FIGURE 15. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG-SUSCEPTIBILITY TESTING, 2020 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY LABORATORY METHODS, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MANTOUX TEST, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY RADIOGRAPHIC METHODS, 2020 VS 2025 (USD MILLION)
FIGURE 20. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 21. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 23. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 24. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 25. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 26. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 27. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 28. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 29. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 31. AUSTRALIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. CHINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. INDIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. INDONESIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. JAPAN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. MALAYSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. PHILIPPINES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. SOUTH KOREA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. THAILAND TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 41. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 43. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. ITALY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. NETHERLANDS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. QATAR TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. SAUDI ARABIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. SOUTH AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. SPAIN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. UNITED ARAB EMIRATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 55. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 56. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 57. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET, BY TYPE
FIGURE 1. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 7. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 8. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 10. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: MARKET DYNAMICS
FIGURE 11. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2020 VS 2025 (%)
FIGURE 13. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025
FIGURE 15. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG-SUSCEPTIBILITY TESTING, 2020 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY LABORATORY METHODS, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MANTOUX TEST, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY RADIOGRAPHIC METHODS, 2020 VS 2025 (USD MILLION)
FIGURE 20. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 21. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 23. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 24. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 25. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 26. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 27. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 28. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 29. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 31. AUSTRALIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. CHINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. INDIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. INDONESIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. JAPAN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. MALAYSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. PHILIPPINES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. SOUTH KOREA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. THAILAND TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 41. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 43. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. ITALY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. NETHERLANDS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. QATAR TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. SAUDI ARABIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. SOUTH AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. SPAIN TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. UNITED ARAB EMIRATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 55. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 56. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 57. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET, BY TYPE
